Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Published on 24/03/202628/03/2026 by Environmental Scientists

Prof. Joaquín María Campos Rosa | Pharmacology | Outstanding Scientist Award

Professor Emeritus of the University of Granada | The University of Granada University | Spain

Prof. Joaquín María Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistry has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design.

Citation Metrics ( Scopus )

4500

3750

3000

2250

1500

750

Citations
3894

h-index
34

i10-index
92

Citations

Documents

h-index

View Google Scholar Profile View ORCID Profile

Featured Publications

Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models

– Journal of Medicinal Chemistry, 2002

Choline kinase inhibitors as a novel approach for antiproliferative drug design

– Oncogene, 1997

Homochiral drugs: a demanding tendency of the pharmaceutical industry

– Current Medicinal Chemistry, 2009

Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells

– Oncogene, 2003

The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner

– PLOS ONE, 2011

Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Published on 13/01/202613/01/2026 by Environmental Scientists

Dr. Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Dr. Faiz Ullah Khan | Pharmacology | Post-Doctoral Fellow at Peking University | Pakistan

Dr. Faiz Ullah Khan is a distinguished researcher and academic in the field of pharmacy and pharmaceutical sciences, currently affiliated with Peking University, where he has made significant contributions to clinical pharmacy, public health, and pharmacovigilance. Dr. Faiz Ullah Khan earned his PhD, MPhil, and PharmD degrees, equipping him with a robust educational foundation in clinical research, drug safety, and evidence-based pharmacy practice. Professionally, Dr. Faiz Ullah Khan has collaborated extensively with leading researchers and institutions globally, including Quaid-i-Azam University, Xi’an Jiaotong University, Prince of Songkla University, Jouf University, and the RCSI School of Pharmacy and Biomolecular Sciences, contributing to numerous international research projects in medication safety, antibiotic stewardship, and disease burden assessments.

Citation Metrics (Google Scholar)

2000

1600

1200

800

400

–

Citations
1659

i10index
45

h-index
23

🟦 Citations 🟥 i10index 🟩 h-index

View Google Scholar Profile

Featured Publications:

Clinical Case Studies on Medication Safety

– Elsevier, 2023 · 245 Citations

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

– Journal of the American College of Cardiology, 2025 · 64 Citations

Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan

– Disaster Medicine and Public Health Preparedness, 2022 · 60 Citations

Global, Regional, and National Trends in Routine Childhood Vaccination Coverage from 1980 to 2023 with Forecasts to 2030: A Systematic Analysis for the Global Burden of Disease

– The Lancet, 2025 · 58 Citations

Knowledge, Attitude and Practices Among Consumers Toward Antibiotics Use and Antibiotic Resistance in Swat, Khyber-Pakhtunkhwa, Pakistan

– Expert Review of Anti-Infective Therapy, 2020 · 58 Citations

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Published on 31/07/202431/07/2024 by Environmental Scientists

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award 🏆. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes 💊. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs 🔬.

PROFILE 📝

Googlescholar

EDUCATION 🎓

🎓 Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 🧪. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE 🔬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. 🧬💉 In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. 📚🧪 As an educator, she has supervised and trained students, fostering future scientific innovation. 🌿👩‍🏫

CONFERENCE POSTER PRESENTATIONS 📊

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) 💉. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🤝

🎓 Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. 📚 Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. 📝 She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS 🏆

🎓 Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. 🌟🔬 Her work contributes significantly to oncology and neurological research. 🧬💼